. The following is a review of the literature related to worksite cervical cancer screening, followed by some key issue s and directions for future research on this topic.
BACKGROUND

Public Health Aspects of Cervical Cancer
Cervical cancer is the 13th most common cancer among U.S. women (Am erican Cancer Society, 2000) . An estimated 12,800 new cases were diagnosed in 2000 and an estimated 4,600 U.S. women died from the disease that same year. In the United States, racial and ethnic disparities in incidence and mortality from cervical cancer have been identified. For example, incidence is higher among Vietnamese and American Indians than among women of other racial and ethnic backgrounds, and higher among Hispanics than non-Hispanics (Martin, 1996; Schiffman, 1996) . Most cervical cancers are diagnosed at the localized stage, and older women and minority women are more likely to be diagnosed with advanced stage disease (Schiffman, 1996) . From 1988 to 1992, cervical cancer incidence rates were similar for younger White women and Black women-approximately 2 per 100,000 (Martin, 1996) . However, among older women the rates diverged, with the highest rate (47 per 100,000) observed for Black women age 85 years and older. Mortality rates of cervical cancer are about twice as high among Black women as among White women, and most deaths occur among women who are at least 50 years old (Lawson, 2000) .
changes (Schiffman, 1996) . If these pre-cancerous cervical changes (and early stage cervical cancer) are detected, the likelihood of survival is almost 100% with appropriate treatment and follow up. Thus, a significant number of cervical cancer deaths could be avoided if all women adhered to current screening and follow up recommendations. In addition, public health recommendations to reduce infection by the human immunodeficiency virus (HIV) and other sexually transmitted diseases (STDs) (e.g., reduce the number of sexual partners) may reduce the risk for cervical cancer. However, condom use may not provide the same protection against human papillomavirus (HPV) infection as it does against HIV infection and several other STDs (Evans, 1995; McClean, 1997) . Persistent infection with HPV types 16 and 18 has been implicated in the etiology of cervical cancer (Schiffman, 1996) .
The U.S. Preventive Services Task Force recommends routine screening with a Pap test for women who have a uterine cervix, beginning with the onset of sexual activity and repeated at least every 3 years, provided the tests have been consistently normal (U.S. Preventive Services Task Force, 1996) . The Task Force notes that based on available evidence, Pap tests might not be necessary for women after age 65 who have had regular previous tests with consistently normal results. The American College of Obstetricians and Gynecologists (ACOG) (1997) recommends that after a woman has had three or more consecutive, satisfactory normal examinations, the Pap test may be performed less frequently at the discretion of a woman's physician.
RATIONALE FOR CERVICAL CANCER SCREENING IN THE WORKPLACE
Employers have incentives for offering health promotion and screening programs, including cervical cancer screening using the Pap test, for employees and their spouses (Fielding, 1984; Stokols, 1995) . Such programs may improve employee morale, enhance the employer's image, and help employees make better decisions about their health and health care services (Modeste, 1994) . Depending on the population screened and screening intervals, the costs associated with cervical cancer morbidity and mortality may be reduced (Letton, 1975) . However, the potential benefits of screening must be weighed against possible negative outcomes such as false positive test results. Assuring appropriate follow up while maintaining privacy and confidentiality is important, and performing a relatively invasive procedure in a workplace setting may be expensive. In addition, employees may distrust and fear their employer is attempting to substitute workplace health care services for comprehensive health care insurance with a full choice of providers.
Workplaces allow access to a high proportion of adults, including women (Sorensen, 1990) . The extent to which workplace screening includes women who would otherwise not be screened for cervical cancer has not been established. The U.S. work force is very diverse and so it is possible for worksites to playa role in reaching some groups of women who have less access to health care and preventive services (Emmons, 1996) . However, the extent to which this is currently true for cervical cancer screening in the United States is unclear.
Many women's health activities, including screening for cancer of the breast (Caplan, 1998; Haynes, 1990) , are well suited for implementation in the workplace. More than half of U.S. women work outside the home, and women constitute an increasing proportion of the work force (Emmons, 1996) . The increasing number of older women in the workplace is likely to make workplace health programs for older women more attractive. Older women have a higher risk of invasive carcinoma of the cervix and are less likely than younger women to have received a recent Pap test (Martin, 1996; Schiffman, 1996) . Workplace programs for cervical cancer screening are well suited for women whose work schedules preclude their attendance at clinics or provider offices during normal business hours (Thornton, 1989) .
METHODS
The authors identified relevant articles through a MEDLINE search of literature published between January 1975 and April 2001. The searches were limited to articles published in English. The authors used the keywords "cervical neoplasms," "mass screening," and "workplace" to scan titles, abstracts, and subject headings in the databases.
STUDIES OF CERVICAL CANCER PREVENTION PROGRAMS IN THE WORKPLACE
The authors found eight evaluation studies of workplace cervical cancer screening programs (see Table) . Only two were conducted in the United States. In 1977, Raphael reported on 7,450 Australian women aged 18 to 64 years who were examined as part of a cancer detection program for working women from 1964 through 1976. The women were employed in a variety of light industries, retail stores, offices, and services in the Sydney, Newcastle, and Wollongong districts. As many as 22 companies (39 centers) were visited annually. Between 5 and 150 women participated at each center. The response rates (i.e., percentage of eligible women who were screened) ranged from 10% to 50% across centers. Many of the women were immigrants with language barriers and different cultural norms. The program included a confidential questionnaire on medical history, breast examination, instruction on self breast examination, skin examination, pelvic examination, Pap smear, and sometimes a rectal examination. Education about cancer and general counseling were also provided.
Screening revealed 237 abnormal Pap tests, 112 of which were moderate to severe dysplasia or carcinoma. The rate for abnormal tests in this series (32 per 1,000 examinations) was higher than that found in New South Wales in 1970 (10 per 1,000) and 1976 (22 per 1,000). The youngest women found to have cervical carcinoma in situ were 21 years old; the majority were age 30 to 39. Women found to have invasive carcinoma of the cervix ranged from age 29 to 54. Collins (1979) described a community clinic for cancer screening established in North Carolina through Raphael, 1977 Collins, 1979 Morris, 1988 Year the combined efforts of an occupational health nurse, company management, the county medical society, the public health department, and a committee on the status of women appointed by the county commissioners. The objectives were to educate plant employees about major cancers occurring in women, detect cases of breast and cervical cancer among employees, and survey female employees to determine how many received regular check ups or performed self breast examinations. The survey was sent to 130 female employees at one of six plants (a furniture producing plant). Questions included a brief medical history and dates of last Pap test and last clinical breast examination. About half of the surveyed women (n = 64) were due for a Pap test, clinical breast examination, or both. The clinic program consisted of a brief medical history questionnaire, distribution of informational pamphlets on cancer of the cervix and breast, cervical cancer screening and breast examinations, and a film on Pap tests and breast examinations. Advertisements for the clinic program were placed throughout the plant and in the plant's newsletter, and the program was 34 advertised to the community through local newspaper and radio stations. O'Reilly (1984) described a clinic for voluntary cervical cancer screening at the Bank of England printing plant in Essex. Cervical cancer screening was offered in conjunction with breast examination, urinalysis, blood pressure measurement, weight check, and counseling about diet and exercise. Of the 900 women employed at the plant, 22% underwent cervical cancer screening at the worksite clinic. Only eligible women, at least 20 years of age, were screened. Eighteen of the women screened had cervical inflammation and one had carcinoma in situ. Factors associated with clinic attendance were convenience (it was offered onsite during working hours and no traveling was involved), acquaintance with nursing staff, having a female examiner, and satisfaction with resuming Pap tests after attending a family planning clinic was no longer relevant. Morris (1988) examined the potential contribution of cervical cancer screening in the workplace among women employed at the Atomic Energy Authority site at Doun- 
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Year of study 1988 1995 to 1998 reay in the United Kingdom. Female practitioners conducted mobile clinic visits on 3 days in September 1986. All female employees (n =350), including those who did not attend the mobile clinic, were asked to complete a medical history questionnaire from which information about cancer screening history was obtained. One third (n = 126) of the female work force attended the mobile screening clinic. Clinical breast examinations and Pap tests were conducted on 109 women, clinical breast examinations on 14 women, and Pap tests on 3 women. Women at least 35 years old were more likely to attend the mobile clinic than were younger women. A number of the women attending the mobile clinic (n = 61) had received screening within the previous 3 years. Only 27 of the women attending the clinic denied ever having a previous Pap test. Thornton (1989) described the results of a mobile screening unit used to facilitate the availability of cervical cancer screening for working women in one district in Great Britain. The service, jointly organized by the District Health Authority, the Women's National Cancer Control Campaign, and the South West Thames Regional Cancer Organization, was offered to all companies employing at least 25 women; 39 of 82 eligible companies (48%) accepted the offer. Cervical cancer screening was primarily provided for women age 40 or older who had not been screened during the previous 3 years. If time was sufficient, younger women were also screened if they had never been screened before or if they had gynecologic symptoms.
Women with a normal Pap test within the previous 3 years, as well as those who had undergone a hysterectomy, were considered ineligible for the study. Screening services were advertised 2 weeks before the arrival of the mobile clinic with posters and leaflets emphasizing the need for cervical cancer screening. Whenever possible, an informal talk was also given to the entire female work force to explain the service and to answer questions. Among the 21 companies with data available to calculate response rates, 91% of eligible women attended the mobile clinic (Thornton, 1989) .
Overall, 1,038 women were screened at the mobile clinic, of whom 869 (84%) were at least 40 years of age. A total of 491 Pap tests was obtained from 850 women with an intact uterus (58%). Of those with an intact uterus, Pap tests were obtained from 45% of (n = 161) women aged under age 40 and 61% of (n = 689) women age 40 and older. Of the 568 women who had Pap tests, 11% (n = 64) had abnormal results. Fifteen women had cervical neoplasia, of whom nine had either never been screened or had last been screened more than 5 years prior. Two additional women, including one with early invasive cancer of the cervix, had previously had abnormal tests for which the recommended follow up was not completed (Thornton, 1989) . Grazzini (1989) conducted a study based on a cervical cancer screening program in Florence, Italy, in which all resident women ages 25 to 60 years were invited to have a Pap test every third year. The investigators contacted eight workplaces in Florence and invited them to participate in a workplace cervical cancer screening 36 study. Of the eight worksites, two (a supermarket and a porcelain factory) agreed to participate. Of 286 eligible women from the two sites, 52% had Pap tests performed at workplace infirmaries. Factors influencing participation were having a Pap test 3 to 10 years prior or having had no Pap test for at least 3 years. No significant difference in response rates was observed according to age.
In 1991, Andren published a descriptive study of the feasibility of providing cervical cancer screening at a "well woman" clinic in an occupational health setting in Great Britain. The clinic was located close to the worksite, operated during working hours, and was staffed by an occupational physician and an occupational health nurse. The screening services included weight check, blood pressure check, clinical breast examination, pelvic examination, Pap test, and urinalysis. The clinic held 75 sessions and saw 475 women. Andren did not report the exact age distribution of women seen, but the age of clinic attendees ranged from younger than age 20 to older than age 60.
Among women with initial abnormal smears returning for follow up, 19 had abnormal repeat tests, and 7 were referred for colposcopy. The clinic's abnormal Pap test detection rate was 115 per 1,000, which was higher than that of other screening facilities used for comparison (33.5 to 43 per 1,000). The women screened were White (92%; n = 382), Asian (6%; n = 23), and Black (2%; n = 10). The results of this feasibility study suggested a "well woman" screening facility close to the workplace and available during working hours successfully attracted women who were not attending other cervical cancer screening facilities. However, based on local demographic data, Asian women in the district may have been underrepresented (Andren, 1991) .
Allen (200 I) examined the effectiveness of a peer delivered intervention designed to increase use of breast and cervical cancer screening. Twenty-six worksites in the vicinity of Boston, Massachusetts were randomly assigned to the intervention or comparison group. Worksites ranged in size from about 250 to 2,800 employees. The intervention consisted of group discussions, outreach, and educational campaigns. Female employees were recruited to serve as peer health advisors, who served as role models for screening behaviors, disseminated breast and cervical cancer information to their coworkers, provided social support, and fostered positive social norms for screening in the workplace.
Based on data collected from two random samples of female employees (n =2,943 at baseline and n =2,747 at follow up), the intervention group was found to have a greater increase in the percentage of women who reported a Pap test (4.7% versus 1.9%). After worksite cluster and age were controlled for, the observed increase in Pap tests was greater in the intervention group (odds ratio = 1.3, 95% confidence interval I to 1.6), suggesting the intervention activities produced a modest increase in cervical cancer screening. The investigators noted the intervention may not have been successful in reaching those most in need of its message (i.e., women who were not in adherence with screening guidelines) (Allen, 2001) .
DISCUSSION
The studies reviewed provide useful information about the feasibility and possible benefits of worksite programs for cervical cancer screening. However, most of the studies reported to date consist of a descriptive study or a cross sectional survey with an observational study design, carried out as part of program evaluation. With one exception (Allen, 2001) , these surveys are limited by the lack of a suitable comparison group and by the use of a nonrandomized design, which introduces the possibility of bias in study findings (Abrams, 1994; Caplan, 1998) .
Few studies have randomized two or more groups of women to examine the effectiveness of interventions to increase cervical cancer screening in comparison with usual care, with outcomes (e.g., cost, satisfaction, adherence to recommended guidelines for Pap testing). Some studies relied on self reported information, which can introduce information bias. Response rates are low in some of these surveys, which raise concerns about response bias. In addition, in some studies, not all of the targeted companies agreed to participate, which is a possible source of selection bias.
Although these surveys provide useful information about the potential impact of workplace interventions that encourage women to undergo cervical screening, the generalizability of these findings to other locations and settings is uncertain. Some differences exist between preventive services available to women in Great Britain and the United States. Studies from the United States show that 10% to 15% of women in the general population never or rarely received screening for cervical cancer, and that 50% to 60% of incident cases of cervical cancer occur among these women (Martin, 1996; Sung, 2000) . These women may not benefit as much from workplace cervical cancer screening programs as from other approaches (e.g., existing community and clinic based outreach and inreach programs providing services to both working and unemployed women).
The eight studies summarized in this article do not provide the information needed to compare the relative costs, benefits, and effectiveness of workplace and community based approaches for cervical cancer screening and follow up. This lack of information especially includes approaches well suited for underserved women, other women at higher risk for this disease, and populations of working women with special needs (e.g., women of retirement age who choose to continue working, women from unique cultural and ethnic backgrounds, migrant or seasonal farm workers). Epidemiologic studies in the United States have suggested women employed in certain service industries (e.g., maids, cleaners, cooks) and agricultural industry may have higher risks of cervical cancer-possibly because of screening behaviors or other lifestyle factors (Sala, 1998; Savitz, 1995) . These women may be less likely to have health insurance through their employer when compared to women employed in other industries.
Routine cervical cancer screening is frequently available in other settings, and the potential effect of worksite screening on the rate of screening among all women in the general population may be relatively small (Thornton, 1989) . Studies conducted to date do not provide information about the sustainability of routine cervical cancer screening in the workplace or the willingness of employers to sponsor such programs over time. Moreover, concerns about the confidentiality of screening test results need to be addressed (Levenstein, 1989; Stokols, 1995) . For cervical cancer screening in the workplace to succeed, there is a need for health care providers skilled in performing Pap tests such as trained occupational health nurses and other providers.
The studies summarized in the Table highlight several inconsistencies and unresolved issues in worksite programs for cervical cancer screening. Some screening programs excluded older women (e.g., those older than age 60) even though the number of these women in the workplace has increased and they may be at increased risk of cervical cancer if not screened at all. Younger women (e.g., those younger than age 40) have been excluded from worksite screening programs because of the belief that younger women have greater access to cervical cancer screening services in other health service sectors as part of reproductive health care (e.g., obstetrics, family planning) (Thornton, 1989) .
In some worksites, cervical cancer screening has been combined with other health promotion and screening services, and at other worksites it has been offered alone. Interest has been increasing in comprehensive cancer control and in multiphasic screening, but the costs, potential benefits, and possible drawbacks of offering multiple screening services to working women have received little attention so far.
SUMMARY AND RECOMMENDATIONS
More information about existing cervical cancer screening programs in workplaces across the United States is needed. This information may be best obtained through a nationally representative survey with appropriate sampling and statistical analysis. Further analyses of existing data from national surveys of health promotion activities in the workplace (Grosch, 1998; U.S. Department of Health and Human Services, 1993) may help provide some of this information.
Additional studies evaluating worksite health programs for cervical cancer screening are also needed. Programs aimed at increasing access to Pap testing among working women should be described and evaluated further. Previous studies rarely employed an experimental (randomized) or quasi-experimental design. The interpretation of results reported to date is often hampered by the possibility of bias due to low response rates or other selection biases, the use of self reported information about the outcomes of interest, and the lack of a clearly defined theoretical framework for the intervention.
Future studies would benefit from validation of self reported information about cervical cancer screening practices, both before and after the intervention, and from the use of a scientifically valid comparison group and a randomized design. In addition to defining the the-
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Coughlin, S.S., Caplan, L.S., &Lawson, H. W AAOHN Journal 2002; 50(1),32-39. screening programs. Periodic health examinations at worksites often provide an excellent opportunity for nurses in the workplace to educate women about the value of Pap tests (Caplan, 1998; Goodspeed, 1988) . Moreover, acquaintance with nursing staff has been shown to improve attendance at a workplace program for cervical cancer screening (O'Reilly, 1984) . In these ways, occupational and environmental health nurses can sustain and enhance their unique contributions to health promotion and screening efforts.
oretical framework for the intervention in terms of behavioral theories (Becker, 1974; Janz, 1984) , future evaluation studies of worksite cervical cancer screening programs should include process evaluation (to monitor the evaluation as it is implemented) and evaluation of the overall effectiveness of the intervention (to determine if the program has the desired effect). More evaluative research is needed to identify other types of worksite interventions that might motivate or otherwise encourage women to take advantage of cervical cancer screening opportunities in the workplace. The diversity of working women should be taken into account. It might be helpful to extend follow up periods to examine the impact of the interventions on both short term and long term behaviors and on the sustainability of worksite screening programs. Studies are also needed related to the cost effectiveness and utility of workplace cervical cancer screening programs in the United States and the relative costs and benefits of alternative interventions for preventing cervical cancer (e.g., comparisons of worksite and community based screening programs for underserved women). Of particular interest are studies that may elucidate how to improve services for women who have never or rarely been screened and other women at higher risk of invasive cervical cancer.
Occupational and environmental health nurses, who have traditionally emphasized disease prevention, have an important role to play in worksite cervical cancer 1 2 3 4 The workplace has become an increasingly important site for disseminating health information and implementing health promotion activities, including cancer screening.
Few studies have focused on the benefits and effectiveness of worksite programs for Pap tests.
It is unclear from studies conducted to date if cervical cancer screening in the workplace is more likely to prevent cervical cancer than alternative approaches outside the workplace.
The occupational and environmental health nurse has an important role to play in worksite cancer screening programs. Health East and is located in beautiful Fort Lauderdale, Florida just 1 mile from the beaches. Holy Cross Hospital is especially noted for its comprehensive programs and commitment to providing an atmosphere of compassion and caring as well as our multidisciplinary team approach which is dedicated toachievingexcellence. 
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